Cornell Licenses DNAStar's Lasergene Sequencing Software | GenomeWeb
NEW YORK (GenomeWeb News) — Bioinformatics company DNAStar today said it has licensed its Lasergene sequence analysis software to Cornell University.
 
Under the four-year agreement, Cornell scientists will use Lasergene anywhere on the campus, DNAStar said.
 
Financial terms of the agreement were not released.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.